Henry Schein Inc. Reports Strong Q3 2025 Results Amid Market Challenges
Henry Schein Inc. has released its third-quarter financial results for fiscal year 2025, showcasing resilience amidst inflationary pressures, a volatile trade environment, and significant changes in healthcare legislation. The company, a leading global provider of healthcare products and services, continues to adapt to a dynamic market landscape, demonstrating solid performance across its diversified segments.
1. Financial Highlights
For the three months ended September 27, 2025, Henry Schein reported net sales of $3.33 billion, reflecting a 5.2% increase compared to the same quarter in the previous year. The growth was primarily driven by the Global Distribution and Value-Added Services segment, which has seen enhanced demand for its comprehensive product offerings.
Income Statement Overview
The company's net income for Q3 2025 reached $101 million, marking a slight increase from $99 million in Q3 2024. Operating income also improved to $164 million from $157 million year-over-year, indicating effective management of operational expenses, which rose only marginally to $862 million from $836 million.
| Nov 2024 | Nov 2025 | |
|---|---|---|
Net Income | 314M | 391M |
Net Income to Non-controlling Interest | 5M | 21M |
Profit | 319M | 412M |
Net Income Continuing | 303M | 401M |
Income Tax Expense | 98M | 125M |
Pretax Income | 401M | 526M |
Non-operating Income | -104M | -119M |
Operating Income | 505M | 645M |
Revenue | 12.49B | 12.93B |
Costs and Expenses | 11.99B | 12.29B |
Cost of Revenue | 8.55B | 8.90B |
Operating Expenses | 3.44B | 3.39B |
Depreciation, Depletion & Amortization | 246M | 257M |
Restructuring Charge | 25M | 119M |
Selling, General & Administrative | 3.10B | 3.01B |
Other Operating Expenses | 69M | 0 |
2. Segment Performance
Global Distribution and Value-Added Services
This segment continues to be a cornerstone of Henry Schein’s operations, contributing significantly to revenue growth. The company has successfully leveraged its diverse product portfolio to offer lower-cost alternatives, which has helped protect gross profit margins despite inflationary pressures.
Global Specialty Products and Global Technology
Both segments have also shown resilience, with continued investments in product development and technology solutions aimed at enhancing customer engagement and operational efficiency. The company reported a gross profit of $1.026 billion, equating to a gross margin of 30.7%.
3. Challenges and Recent Developments
Cyber Incident and Economic Conditions
In October 2023, Henry Schein faced a cyber incident affecting its North American and European operations. The incident resulted in decreased sales to episodic customers and incurred expenses of $3 million in Q3 2025. However, insurance recoveries of $30 million have mitigated some of the financial impact.
Additionally, new tariffs imposed on imports have created a volatile trade landscape, but these have not materially affected Henry Schein's operations thus far. The company remains vigilant in monitoring how these tariffs could impact future sales.
Legislative Changes
The recently enacted "One Big Beautiful Bill Act" (OBBBA), signed into law on July 4, 2025, presents potential challenges. The legislation is expected to reduce Medicaid enrollees and federal funding to state Medicaid programs, which could impact service utilization and product coverage.
4. Liquidity and Capital Resources
Henry Schein maintains robust liquidity, supported by net cash provided by operating activities totaling $331 million for the nine months ended September 27, 2025. The company generated a net cash flow from operating activities of $174 million during Q3, demonstrating strong operational performance.
Cash Flow Overview
Despite a slight decline in cash flow compared to the previous year, the company remains committed to its acquisition strategy. The recent authorization of a $750 million share repurchase plan reflects Henry Schein's commitment to returning value to shareholders.
| Nov 2024 | Nov 2025 | |
|---|---|---|
Net Change in Cash | -40M | 10M |
Effect of Exchange Rate Changes | -41M | -28M |
Net Cash from Operating Activities | 612M | 535M |
Operating Profit | 319M | 412M |
Adjustment to Operating Profit | 293M | 123M |
Net Cash from Investing Activities | -699M | -311M |
Business & Interest in Affiliates | 510M | 119M |
Investments | 1M | 1M |
Productive Assets | 151M | 132M |
Other Investing Activities | -37M | -59M |
Net Cash from Financing Activities | 88M | -186M |
Debt | 751M | 431M |
Equity Issuance/Repurchase | -357M | -471M |
Other Financing Activities | -306M | -146M |
5. Balance Sheet Position
As of September 27, 2025, Henry Schein reported total assets of $11.09 billion, with total liabilities of $6.19 billion. The company's equity stands at $4.02 billion, driven by retained earnings of $3.37 billion.
| Nov 2024 | Nov 2025 | |
|---|---|---|
Total Assets | 10.60B | 11.09B |
Total Current Assets | 4.14B | 4.39B |
Cash and Equivalents | 126M | 136M |
Net Inventories | 1.75B | 1.91B |
Accounts Receivable | 1.66B | 1.74B |
Prepaid Expenses | 607M | 604M |
Total Non-current Assets | 6.45B | 6.70B |
Intangible Assets | 5.08B | 5.19B |
Long-term Investments | 528M | 598M |
Net PP&E | 540M | 603M |
Lease Assets | 304M | 308M |
Total Liabilities and Equity | 10.60B | 11.09B |
Temporary Equity and Redeemable Non-controlling Interest | 832M | 877M |
Total Liabilities | 5.63B | 6.19B |
Total Current Liabilities | 2.92B | 3.14B |
Accounts Payable and Accrued Liabilities | 1.47B | 1.50B |
Current Debt | 824M | 1.02B |
Other Current Liabilities | 631M | 618M |
Total Non-current Liabilities | 2.70B | 3.04B |
Long-term Debt | 1.90B | 2.15B |
Non-current Deferred Tax Liabilities | 123M | 144M |
Other Non-current Liabilities | 676M | 751M |
Total Equity and Non-controlling Interests | 4.13B | 4.02B |
Total Equity | 3.50B | 3.36B |
Non-controlling Interests | 636M | 662M |
6. Future Outlook
Looking ahead, Henry Schein Inc. plans to continue focusing on operational efficiencies and strategic acquisitions to expand its market presence. The aging population and increasing healthcare awareness are expected to drive demand for healthcare services and products, positioning the company favorably for future growth.
Conclusion
Henry Schein Inc. has successfully navigated a challenging market environment in Q3 2025, demonstrating a commitment to strategic growth and operational efficiency. With a robust product offering and a focus on customer service, the company is well-positioned to capitalize on emerging opportunities within the healthcare industry. As it moves forward, maintaining adaptability in the face of regulatory changes and market dynamics will be key to its continued success.
